MADRIGAL PHARMACEUTICALS INC has a total of 107 patent applications. It increased the IP activity by 25.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ST IP HOLDING AG, NEUROGENETIC PHARMACEUTICALS INC and RPG LIFE SCIENCES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | EPO (European Patent Office) | 15 | |
#3 | Australia | 13 | |
#4 | Israel | 8 | |
#5 | Republic of Korea | 8 | |
#6 | Japan | 7 | |
#7 | WIPO (World Intellectual Property Organization) | 7 | |
#8 | China | 6 | |
#9 | Canada | 5 | |
#10 | Taiwan | 5 | |
#11 | New Zealand | 4 | |
#12 | Singapore | 3 | |
#13 | Argentina | 2 | |
#14 | Mexico | 2 | |
#15 | Hong Kong | 1 | |
#16 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Ying Weiwen | 44 |
#2 | Chimmanamada Dinesh U | 43 |
#3 | Taub Rebecca | 30 |
#4 | Wang Ping | 27 |
#5 | Shu Lianhe | 27 |
#6 | Dong Gang | 26 |
#7 | Choi Duk Soon | 22 |
#8 | Chasnoff Anna | 22 |
#9 | Zhang Junyi | 18 |
#10 | Duguid Robert J | 18 |
Publication | Filing date | Title |
---|---|---|
AR115666A1 | SOLID FORMS OF 2- (3,5-DICHLORO-4 - ((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-IL) OXY) PHENYL) -3,5-DIOXO-2,3,4 , 5-TETRAHYDRO-1,2,4-TRIAZIN-6-CARBONITRILE | |
CN110799194A | Combination therapy comprising targeted therapeutic agents | |
CN111511364A | Targeted therapeutic agents | |
CA3040888A1 | Methods of treating liver disorders or lipid disorders with a thr-beta agonist | |
EP3791897A1 | Hsp90 inhibitor drug conjugates | |
EP3738594A1 | Targeted therapeutics having an hsp90 ligand as binding moiety | |
NZ746295A | Use of compounds of formula (iv) in the manufacture of a medicament for treating thyroid hormone resistance-associated diseases | |
SG10201705984XA | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
CN110559446A | Targeted therapeutics |